Decision Aid for Breast Cancer Surgery Choices

Recruiting in Palo Alto (17 mi)

+57 other locations

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Alliance for Clinical Trials in Oncology

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial studies how well a breast cancer surgery decision aid works in increasing patient engagement in decision making for patients with newly diagnosed stage 0-III breast cancer. The trial also examines barriers to patient engagement even with the use of a decision aid, and if barriers are more likely to be experienced by socioeconomically disadvantaged patients.

Eligibility Criteria

This trial is for English-speaking patients newly diagnosed with stage 0-III breast cancer who are planning surgery as part of their treatment. Surgeons and care staff at participating clinics must consent to the study. Patients with impaired decision-making capacity or hearing impairment requiring an interpreter are excluded.

Inclusion Criteria

You were recently diagnosed with early-stage breast cancer.

Doctors, nurses, assistants, and other healthcare providers who help treat people with newly diagnosed breast cancer at the clinic.

Eligible patients must be planning breast surgery as a component of their definitive treatment

+2 more

Exclusion Criteria

Hospitals that do not perform surgery on 120-300 new breast cancer patients each year.

Patients with impaired decision-making capacity (such as with a diagnosis of dementia or memory loss) are not eligible for this study

Patients with hearing impairment requiring the use of an interpreter are not eligible for this study

Participant Groups

The study compares usual care against a web-based decision aid designed to increase patient engagement in surgical decisions for breast cancer. It also explores barriers to engagement, particularly among socioeconomically disadvantaged patients.

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm II (web-based breast cancer surgery decision aid)Experimental Treatment2 Interventions

Following a 10 week implementation period, at the time of institutional crossover, participants will receive a web-based decision aid prior to the surgical consultation..

Group II: Arm I (surgical consultation)Active Control1 Intervention

Prior to institutional crossover, participants receive care as per usual care.